Detalles de la búsqueda
1.
When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
Cult Health Sex
; 18(9): 1081-91, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27093238
2.
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial.
J Acquir Immune Defic Syndr
; 71(4): 452-61, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536315
3.
Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
AIDS Patient Care STDS
; 29(9): 503-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26196411
4.
Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP.
PLoS One
; 10(6): e0129177, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056842
5.
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
J Acquir Immune Defic Syndr
; 68(5): 578-84, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25761233
6.
The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa.
PLoS One
; 9(9): e106410, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25229403
7.
A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.
J Int AIDS Soc
; 17(3 Suppl 2): 19152, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25224613
Resultados
1 -
7
de 7
1
Próxima >
>>